Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial.

Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial. Eur J Heart Fail. 2018 12; 20(12):1701-1709.

View in: PubMed

subject areas

Aged
Aminobutyrates
Angiotensin Receptor Antagonists
Biomarkers
Biphenyl Compounds
Disease Progression
Drug Combinations
Enzyme-Linked Immunosorbent Assay
Female
Follow-Up Studies
Growth Differentiation Factor 15
Heart Failure
Humans
Male
Middle Aged
Stroke Volume
Tetrazoles
Time Factors
Treatment Outcome
Valsartan

authors with profiles

Michael R. Zile